Schedule 13G ownership disclosure

DICE THERAPEUTICS INC

Security class unavailable · CUSIP: 23345J104

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,219,960
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-23-002751
Form type
SC 13G
Filer
DICE Therapeutics, Inc.
CIK
CIK 1645569
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub